Velan Capital Investment Management LP
Position in ANTX — AN2 Therapeutics, Inc.
CIK 1848809
ALPHARETTA, GA
Position in ANTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$193,600
New position
Shares Held
40,000
first reported quarter
Ownership
0.106%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#38
of 66 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Velan Capital Investment Management LP holds $153,684,284 across 45 Biotechnology names. ANTX ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
88,781 | $29,722,990 | |
| 2 | MPLT |
MapLight Therapeutics, Inc.
|
492,893 | $17,665,285 | |
| 3 | STRO |
Sutro Biopharma, Inc.
|
512,160 | $17,003,712 | |
| 4 | IMMX |
Immix Biopharma, Inc.
|
1,085,000 | $11,186,350 | |
| 5 | TARA |
Protara Therapeutics, Inc.
|
2,844,652 | $10,866,570 | |
| 6 | ABVX |
Abivax S.A.
|
65,630 | $8,745,853 | |
| 7 | TENX |
Tenax Therapeutics, Inc.
|
549,985 | $8,002,281 | |
| 8 | EDSA |
Edesa Biotech, Inc.
|
827,500 | $6,727,575 |
All Filings in ANTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193,600 | 40,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||